Real-World Study Evaluates Semaglutide for Severe Obesity in Diverse Patient Groups
SEMASEARCH Study Design: Real-World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials.
Abstract
SEMASEARCH Study Design: Real-World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials.
Authors: Bel Lassen P, Jacobi D, Brindisi MC, Bonnet JB, Subtil F, Bin S, Abad F, Poitou C, Segrestin B…
TitrateLab articles covering Semaglutide
Written by TitrateLab, separately from the study summarized above.
